Contemporary use of guideline-based higher potency P2Y12 receptor inhibitor therapy in patients with moderate-to-high risk non-ST-segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross-sectional study
当前在中高危非ST段抬高型心肌梗死患者中应用基于指南的高效力P2Y12受体抑制剂疗法:来自加拿大ACS反思II横断面研究的结果
期刊:Clinical Cardiology
影响因子:2.3
doi:10.1002/clc.23618
Patel, Ashish; Goodman, Shaun G; Tan, Mary; Suskin, Neville; McKelvie, Robert; Mathew, Andrew L; Lutchmedial, Sohrab; Dehghani, Payam; Lavoie, Andrea J; Huynh, Thao; Lavi, Shahar; Philipp, Roger; Khan, Razi; Yan, Andrew T; Radhakrishnan, Sam; Sedlak, Tara; Brunner, Nathan; Kim, Hahn Hoe; Cieza, Tomas; Kassam, Saleem; Fordyce, Christopher B; Heffernan, Michael; Jedrzkiewicz, Sean; Madan, Mina; Ahmed, Shaheeda; Barry, Colin; Dery, Jean-Pierre; Bagai, Akshay